Use of chemoprotectants in chemotherapy and radiation therapy: the challenges of selecting an appropriate agent
| Autor: | Gopabandhu Jena, Ajit Vikram, Poduri Ramarao, Durga Nand Tripathi |
|---|---|
| Rok vydání: | 2010 |
| Předmět: |
medicine.medical_specialty
Radiation-Sensitizing Agents medicine.medical_treatment Antineoplastic Agents Protective Agents Antioxidants Intervention (counseling) Neoplasms Medicine Chemoprotectants Humans Intensive care medicine Selection (genetic algorithm) Neoplasm Staging Randomized Controlled Trials as Topic Chemotherapy business.industry Chemoprotection Cancer medicine.disease Surgery Radiation therapy Complementary and alternative medicine Oncology Dietary Supplements Cancer development business |
| Zdroj: | Integrative cancer therapies. 9(3) |
| ISSN: | 1552-695X |
| Popis: | Chemoprotection refers to the protection from the toxicity of one chemical by the intervention of another. Conflicting preclinical and clinical reports make it difficult to either ignore or accept the use of chemoprotectants during cancer chemotherapy or radiotherapy. The selection of anticancer drugs depends on the type and stage of cancer development. However, very little attention has been paid to the selection of chemoprotectants.The answer to the use of chemoprotectants during cancer therapy lies in their appropriate selection in a case-specific and/or issue-specific manner. The need of the hour is to find better answers on the rationality of chemoprotectants selection during cancer therapy using cutting-edge science. In this commentary, we have presented few examples to justify our view-points. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|